While momentous, the approval of Cobenfy could also draw attention to an age-old problem in American healthcare: Will insurance barriers keep patients from getting an effective medicine?
A medicine that sidesteps the brain's dopamine receptors to reach different targets represents a new approach to ...
New schizophrenia drug ‘could change the lives of millions of people’ - The US Food and Drug Administration has approved ...
U.S. FDA Approves Bristol Myers Squibb’s COBENFY, a First-In-Class Muscarinic Agonist for the Treatment of Schizophrenia in Adults ...
When a rash broke out on the hand of a patient taking part in the trial of a promising schizophrenia drug, clinical investigator Greg Mattingly began to fret that it might be an allergic reaction.
A Coventry man who persistently harassed his neighbours has been jailed. Ranjit Sadra would knock on doors at 3am asking for money and would aggressively beg in the streets around Cheylesmore.
Background: Drug misuse is an important clinical problem associated with a poorer outcome in patients who have a diagnosis of schizophrenia. Qualitative studies have rarely been used to elicit ...
Terence Flynn, an analyst from Morgan Stanley, maintained the Sell rating on Bristol-Myers Squibb (BMY – Research Report). The associated ...
Plumes of smoke filled the air around a road in Coventry due to a 'significant fire'. Crews from Foleshill and Coventry fire stations raced to the scene in Sydnall Road last night (September 23).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback